Yüksel Ürün
@yukselurun.bsky.social
📤 597
📥 113
📝 197
Medical Oncologist 🔬 @AnkaraUni 🎓 Advocate for
#Diversity
&
#Equity
🌟 Genitourinary Cancer
reposted by
Yüksel Ürün
OncoDaily
22 days ago
Three Words, One Mission - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/voices/yukse...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#ESMO
#ESMO25
#ESMO2025
loading . . .
Yüksel Ürün: Three Words, One Mission - OncoDaily
Yüksel Ürün: Three Words, One Mission / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, OncoDaily, Oncology, Yüksel Ürün
https://oncodaily.com/voices/yuksel-urun-392904
0
6
1
reposted by
Yüksel Ürün
OncoDaily
21 days ago
Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC - Yüksel Ürün
@yukselurun.bsky.social
@erikahamilton9.bsky.social
oncodaily.com/voices/yukse...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#ESMO
#ESMO25
#ESMO2025
loading . . .
Yüksel Ürün: Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC - OncoDaily
Yüksel Ürün: Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC / cancer, Erika Hamilton, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, OncoDaily,
https://oncodaily.com/voices/yuksel-urun-394296
0
4
1
reposted by
Yüksel Ürün
OncoDaily
27 days ago
Global Cancer Burden Calls for Action on Prevention and Equity - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/voices/yukse...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
loading . . .
Yüksel Ürün: Global Cancer Burden Calls for Action on Prevention and Equity - OncoDaily
Yüksel Ürün: Global Cancer Burden Calls for Action on Prevention and Equity / cancer, OncoDaily, Oncology, Yüksel Ürün
https://oncodaily.com/voices/yuksel-urun-389707
0
5
1
Proud to join such inspiring colleagues as an
#ESMOAmbassadors
Excited for
#ESMO25
and all the new
#CancerResearch
ahead.
@myesmo.bsky.social
add a skeleton here at some point
30 days ago
1
4
0
reposted by
Yüksel Ürün
ESMO - European Society for Medical Oncology
about 1 month ago
@ptarantinomd.bsky.social
;
@yukselurun.bsky.social
;
@arndtvogel.bsky.social
;
@tiansterzhangmd.bsky.social
0
3
2
Hastalarımıza gerçeği anlatmak. Ne korku satmak, ne de sahte umut vermek. Medya, veriyi dürüst anlattığında güç katar. Ama çarpıtılmış grafikler, abartılmış başlıklar, seçilmiş veriler… Korku yaratır. Umudu kirletir. Gerçeği savunmak, hastalarımızı korumaktır. Veri konuşsun, biz dinleyelim.
30 days ago
0
0
0
Cancer care often forgets those at the edges: teens, elders, people with rare cancers. Their needs don’t fit the standard path. Fertility, intimacy, body image deserve the same care as the tumor.
@oncoalert.bsky.social
@oncoassist.bsky.social
about 1 month ago
0
2
0
Every patient is first a human being with a name, a story, a dream. Dignity is part of the treatment. Never reduce a life to a diagnosis…
@ascocancer.bsky.social
@myesmo.bsky.social
@oncoalert.bsky.social
about 1 month ago
0
2
0
Proud of our rising star Coşkun and all colleagues. This meta-analysis on PARP inhibitors and thrombosis risk asks the right question for patients.
@oncoalert.bsky.social
@myesmo.bsky.social
@apccc.bsky.social
@drchoueiri.bsky.social
@neerajagarwal.bsky.social
about 1 month ago
0
1
1
“Medice, cura te ipsum” Doctor, heal yourself. Even healers burn out. Rest is not weakness, it is repair. Caring for others starts with caring for yourself.
@oncoalert.bsky.social
@oncbrothers.bsky.social
@ascocancer.bsky.social
@myesmo.bsky.social
about 2 months ago
1
2
0
reposted by
Yüksel Ürün
OncoDaily
about 2 months ago
Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting
@yukselurun.bsky.social
oncodaily.com/pulse/dr-yuk...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#VIRO
#VIRO25
loading . . .
Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting - OncoDaily
Dr. Yüksel Ürün at VIRO 2025 shares insights on personalizing frontline kidney cancer treatment, emphasizing biology and patient-centered care.
https://oncodaily.com/pulse/dr-yuksel-urun-at-viro2025
0
2
1
reposted by
Yüksel Ürün
OncoDaily
2 months ago
Join Us for Global Voices in Renal Oncology Virtual Congress 2025
@yukselurun.bsky.social
oncodaily.com/pulse/global...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
0
9
4
Global voices, shared hope. Excited to join colleagues at VIRO 2025—working together for patients in renal cancer.
#OncoDaily
#VIRO2025
@oncodaily.bsky.social
docs.google.com/forms/d/e/1F...
2 months ago
0
3
0
reposted by
Yüksel Ürün
OncoDaily
3 months ago
🌍 𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗼𝗶𝗰𝗲𝘀 𝗶𝗻 𝗥𝗲𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗩𝗜𝗥𝗢) 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 📅 Sept 11–12, 2025 | 🩺 Chaired by Dr. Rana McKay & co-chaired by Dr. Yüksel Ürün
@yukselurun.bsky.social
🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲:
forms.gle/qcQyaGMQfHDh...
oncodaily.com/pulse/rana-m...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
0
6
1
reposted by
Yüksel Ürün
OncoDaily
3 months ago
Meet the Experts of VIRO 2025 - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/pulse/yuksel...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
loading . . .
Yüksel Ürün: Meet the Experts of VIRO 2025
Prof. Yüksel Ürün is a distinguished Professor of Medical Oncology at Ankara University School of Medicine and one of Turkey’s leading experts in
https://oncodaily.com/pulse/yuksel-urun-meet-the-experts-of-viro-2025
0
6
1
reposted by
Yüksel Ürün
OncoDaily
2 months ago
Liquid Biopsy Is No Longer the Future - Yüksel Ürün
@yukselurun.bsky.social
@neerajagarwal.bsky.social
@euplatinum.bsky.social
oncodaily.com/science/liqu...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#LiquidBiopsy
loading . . .
Yüksel Ürün: Liquid Biopsy Is No Longer the Future - OncoDaily
Yüksel Ürün: Liquid Biopsy Is No Longer the Future / Antonio Alcaraz, Benjamin L Maughan, cancer, Emmanuel S Antonarakis, genitourinary malignancies, Lars
https://oncodaily.com/science/liquid-biopsy-355611
0
6
1
reposted by
Yüksel Ürün
OncoDaily
2 months ago
Cancer Prevention is the Quiet Revolution - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/voices/yukse...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
loading . . .
Yüksel Ürün: Cancer Prevention is the Quiet Revolution - OncoDaily
Yüksel Ürün: Cancer Prevention is the Quiet Revolution / cancer, Cancer Prevention, Cancer research, OncoDaily, Oncology, Yüksel Ürün
https://oncodaily.com/voices/yuksel-urun-357870
0
4
1
Every patient teaches me something new about strength, hope, and why we fight.
3 months ago
1
2
0
reposted by
Yüksel Ürün
OncoDaily
4 months ago
Science Is Better When It’s Shared - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/blog/science...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#Science
loading . . .
Yüksel Ürün: Science Is Better When It’s Shared - OncoDaily
Yüksel Ürün: Science Is Better When It’s Shared / cancer, Headlines, OncoDaily, Oncology, Yüksel Ürün
https://oncodaily.com/blog/science-327732
0
9
2
reposted by
Yüksel Ürün
OncoDaily
4 months ago
Breast Cancer Care Shouldn’t Be a Luxury - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/insight/yuks...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#BreastCancer
loading . . .
Yüksel Ürün: Breast Cancer Care Shouldn’t Be a Luxury - OncoDaily
Yüksel Ürün: Breast Cancer Care Shouldn’t Be a Luxury / Amal Arahmani, Ander Urruticoechea, Ankara University School of Medicine, Barbro Lindholm, Boon H.
https://oncodaily.com/insight/yuksel-urun-330433
0
10
2
reposted by
Yüksel Ürün
Priya Patel
4 months ago
This sounds like an exciting step forward! How soon do you think cancer vaccines like these could become more widely used?
0
1
1
reposted by
Yüksel Ürün
OncoDaily
3 months ago
A Promising Option for Non–Non-Clear-Cell Renal Cell Carcinoma - Yüksel Ürün
@yukselurun.bsky.social
@euplatinum.bsky.social
oncodaily.com/science/yuks...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#nccRCC
#KidneyCancer
loading . . .
Yüksel Ürün: A Promising Option for Non–Clear-Cell Renal Cell Carcinoma - OncoDaily
Yüksel Ürün: A Promising Option for Non–Clear-Cell Renal Cell Carcinoma / cancer, Craig Gedye, Cristina Suárez, David Pook, Erhan Gokmen, european urology,
https://oncodaily.com/science/yuksel-urun-336370
0
8
1
reposted by
Yüksel Ürün
OncoDaily
3 months ago
How Should We Treat mCRPC and HRR Deficiency? - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/blog/how-sho...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#mCRPC
#HRR
#ProstateCancer
loading . . .
Yüksel Ürün: How Should We Treat mCRPC and HRR Deficiency? - OncoDaily
Yüksel Ürün: How Should We Treat mCRPC and HRR Deficiency? / Ankara University School of Medicine, cancer, HRR Deficiency, mCRPC, metastatic
https://oncodaily.com/blog/how-should-we-treat-341267
0
6
1
reposted by
Yüksel Ürün
OncoDaily
4 months ago
First Positive Phase 3 Trial for a Bispecific ADC - Paolo Tarantino
@ptarantinomd.bsky.social
@yukselurun.bsky.social
oncodaily.com/insight/paol...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#ADC
loading . . .
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC - OncoDaily
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC / ADCs, Biokin Pharma, BMS, cancer, Minhua Chu, OncoDaily, Oncology, Paolo Tarantino,
https://oncodaily.com/insight/paolo-tarantino-323147
0
9
2
Cancer vaccines: the next frontier is now. From HBV & HPV to personalized mRNA shots
@oncoalert.bsky.social
@oncoassist.bsky.social
@ptarantinomd.bsky.social
@drchoueiri.bsky.social
@viveksubbiah.bsky.social
4 months ago
1
4
1
Take care of your kidneys, protect your life. 4 simple actions = less risk, better outcomes: 🚭 Quit smoking ⚖️ Stay at a healthy weight 🏃♀️ Be active, avoid trauma 💧 Drink water, skip alcohol Because prevention is power
@oncoalert.bsky.social
@drchoueiri.bsky.social
@kidneycan.bsky.social
5 months ago
0
3
1
🎗 Gerçek bilim bazen zor konuşur. Herkes “mucize” ister, ama biz sabırla örülmüş gerçekleri anlatırız. 📌 Evet, süreç yorucu. 📌 Evet, sonuç her zaman adil değil. Ama geçmişe göre çok daha iyiyiz. Birçok tümörde, yıllar kazandıran tedaviler var artık
5 months ago
0
0
1
Bugünkü kelimemiz: Radikal Prostatektomi 🧬 Prostat kanseri tedavisinde sık kullanılan bu kelime, aslında ne demek? 👨⚕️ Prostat bezinin tamamen çıkarıldığı bir ameliyat. Genellikle erken evredeki hastalarda uygulanır. 🎯 Bilmek güç verir. Takipte kalın, diğer terimleri de birlikte öğrenelim.
5 months ago
0
0
0
🔬 Klinik Araştırma Nedir? Kanser gibi ciddi hastalıklar için daha etkili, daha güvenli tedaviler geliştirmek amacıyla yürütülen bilimsel çalışmalardır. Her klinik araştırma; hem bugünün hastalarına yeni bir tedavi seçeneği sunar, hem de gelecekte binlerce hayatın değişmesine katkı sağlar.
#science
5 months ago
1
1
0
Biyopsi = Şüpheli dokudan parça alıp mikroskopla incelemek. Örneğin: “Mesanedeki kitlenin ne olduğunu anlamak için biyopsi yapıldı.” 🎯 Çünkü doğru tanı, doğru tedavinin ilk adımıdır.
5 months ago
0
0
0
reposted by
Yüksel Ürün
Ananya Choudhury
5 months ago
I have two favourite studies from
#ASCO25
@christielibrary.bsky.social
@mcrcnews.bsky.social
👇🏽
www.nejm.org/doi/full/10....
loading . . .
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer | NEJM
Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. In this phase 3, randomized trial conducted at 55 centers, ...
https://www.nejm.org/doi/full/10.1056/NEJMoa2502760
2
10
3
reposted by
Yüksel Ürün
Dr. Rishi Wadhera, MD MPP MPhil
5 months ago
Our new JAMA Cardiology study finds that many US adults don't know that they have hypertension, diabetes, or high cholesterol Nearly 1 in 3 young adults w/ hypertension, 2 in 5 with diabetes, and 1 in 4 with high cholesterol are unaware of their condition.
bit.ly/45an6MC
#medsky
#cardiosky
loading . . .
Hypertension, Diabetes, and High Cholesterol Awareness Among US Adults
This cross-sectional study evaluated the changes in the proportion of US adults who were unaware they had hypertension, diabetes, or a high cholesterol level using 2013 to 2023 data from the National ...
https://jamanetwork.com/journals/jamacardiology/article-abstract/2835026
2
42
20
reposted by
Yüksel Ürün
Ying Ge
5 months ago
#ASMS2025
ThP046 come to check out Jenny’s poster! Don’t miss this great opportunity to meet Jenny!
@asms.org
@jyates.bsky.social
@femalesinms.bsky.social
#teammassspec
@garcialabms.bsky.social
@proteomicsnews.bsky.social
0
14
4
reposted by
Yüksel Ürün
Deb Collyar
5 months ago
This is so true. We have to continually work together to get better
#healthcare
delivery &
#research
advances to ALL
#patients
.
add a skeleton here at some point
0
1
1
Every oncologist is a patient advocate. Right treatment. Right time. For every patient.
#ASCO25
#Oncology
#CancerCare
#AccessMatters
@oncoalert.bsky.social
@ascocancer.bsky.social
@viveksubbiah.bsky.social
@ptarantinomd.bsky.social
@oncbrothers.bsky.social
5 months ago
0
5
3
Thrilled to share our new analysis from CheckMate 901! 🟡In N+ only metastatic UC, Nivolumab + chemo doubled complete response rate vs chemo alone (63% vs 34%) and prolonged PFS and OS. ➡️A new horizon for a distinct subgroup. @uroweb.org
@oncoalert.bsky.social
@oncbrothers.bsky.social
6 months ago
0
1
1
📢 Just in: Multivitamins after MI in diabetes? 🔬 In this RCT (n=1000), oral multivitamins didn't reduce CV events after MI in patients with diabetes. 🎯 35% event rate in both arms HR: 0.99 No benefit.
#Cardiology
#Diabetes
#RCT
#JAMA
6 months ago
0
0
0
reposted by
Yüksel Ürün
OncoDaily
6 months ago
Longitudinal ctDNA profiling in mCRPC reveals how Tumors evolve - Yüksel Ürün
@yukselurun.bsky.social
oncodaily.com/science/yuks...
#OncoDaily
#Oncology
#Cancer
#Health
#Medicine
#MedEd
#MedOnc
#MedNews
#ctDNA
#mCRPC
#ProstateCancer
loading . . .
Yüksel Ürün: Longitudinal ctDNA profiling in mCRPC reveals how Tumors evolve - OncoDaily
Yüksel Ürün: Longitudinal ctDNA profiling in mCRPC reveals how Tumors evolve / Amado J Zurita, Ana M. Aparicio, Ankara University School of Medicine, cancer,
https://oncodaily.com/science/yuksel-urun-288134
0
8
2
New era for HER2-mutant lung cancer! Zongertinib delivered a 71% response rate, 12.4 months median PFS! No ILD reported. Precision hitting its mark!
#LungCancer
#Oncology
#Targeted
#cancerresearch
@nejm.org
@oncoalert.bsky.social
@viveksubbiah.bsky.social
@ptarantinomd.bsky.social
6 months ago
0
5
3
Abstracts are out for
#ASCO25
! 5000+ studies. 5 Plenary game-changers.
@ascocancer.bsky.social
@oncoalert.bsky.social
@drchoueiri.bsky.social
@ptarantinomd.bsky.social
@viveksubbiah.bsky.social
@oncbrothers.bsky.social
7 months ago
0
6
1
The ESMO Research Fellowship is now open. A chance to dive deep into science, grow globally, and shape the future of cancer care. Ready to make impact?
@myesmo.bsky.social
@oncoalert.bsky.social
@ptarantinomd.bsky.social
@antoniopassaro.bsky.social
@drchoueiri.bsky.social
add a skeleton here at some point
7 months ago
0
3
0
reposted by
Yüksel Ürün
Dr Joseph McCollom DO
7 months ago
Many kudos to
@ascocancer.bsky.social
amazing
#SoMe
staff for putting together this great highlight of
#ASCO25
planning. Getting a moment to hang with the real stars 🤩 inc
@ryannipp.bsky.social
and my
#MedEd
colleagues. Looking forward to May in Chicago 🌃
add a skeleton here at some point
1
10
4
Thrilled to announce that our article has been selected as a Top Viewed Article in Cancer journal! “Cancer-associated thrombosis and drug–drug interactions of antithrombotic/antineoplastic agents” Thank you for reading, sharing making science matter
@oncoalert.bsky.social
@ascocancer.bsky.social
7 months ago
0
2
0
reposted by
Yüksel Ürün
Jose Tapia
7 months ago
Grateful to be included on this list alongside such great minds as Dr
@yukselurun.bsky.social
Much appreciated, @Larvol 😊
add a skeleton here at some point
0
1
1
What if we screened smarter, not just more? In BARCODE1, men with high polygenic risk (top 10%) had MRI + biopsy— 40% had prostate cancer. Over half needed treatment. Most would’ve been missed by PSA alone. Genetics is rewriting the rules.
@nejm.org
@myesmo.bsky.social
@oncoalert.bsky.social
7 months ago
0
3
3
🧬 Genomic testing in childhood & young adult cancers: 🧬16–18% carry germline variants 🧬Somatic findings guide Dx in up to 95% 🧬Matched therapy? Often possible—rarely given The science is ready. Let’s make care catch up.
@oncoalert.bsky.social
@viveksubbiah.bsky.social
@ptarantinomd.bsky.social
7 months ago
1
2
1
🧬 Bigger isn’t always better— In this randomized trial, a large 324-gene panel (F1CDX) identified more matched therapies vs. a smaller panel (51.6% vs 36.9%, +14.8%) But… no survival benefit seen. More targets ≠ better outcomes—yet.
@oncoalert.bsky.social
@viveksubbiah.bsky.social
rdcu.be/egWk9
7 months ago
0
2
0
I’m always inspired by the brilliant minds on this list (and many others!) who generously share insights and push the field of oncology forward. Grateful to @larvol for the inclusion.
@ascocancer.bsky.social
7 months ago
0
1
1
Can a shingles vaccine protect the brain? Zoster vaccination linked to a 20% lower risk of dementia over 7 years.
@nature.com
rdcu.be/egydp
7 months ago
0
2
1
TIL therapy + pembrolizumab (SEL-TIL + P) shows 23.5% response in mismatch repair–proficient GI cancers—where immunotherapy usually fails. Neoantigen recognition may be the key.
@oncoalert.bsky.social
@nature.com
@viveksubbiah.bsky.social
@jameabraham.bsky.social
7 months ago
0
1
0
Load more
feeds!
log in